ro5285119
Small moleculeexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01418963)
Timeline
Indications
Mechanism of action
- Vasopressin V1a receptorANTAGONIST
AVPR1A antagonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545342 ↗
Also known as
- rg7314
- rg7314
- rg-7314
- rg-7314
- ro5285119
- ro-5285119
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02901431 | Phase 2 | Nov 30, 2016 | Roche |
| NCT02205073 | Phase 1 | Jul 1, 2014 | Roche |
| NCT02179866 | Phase 1 | Jun 1, 2014 | Roche |
| NCT01967979 | Phase 1 | Oct 1, 2013 | Roche |
| NCT01793441 | Phase 2 | Sep 1, 2013 | Roche |
| NCT01708616 | Phase 1 | Nov 1, 2012 | Roche |
| NCT01418963 | Phase 1 | Jul 1, 2011 | Roche |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 7 | 7 | 2 | 2011 |
1 organizations
Page 1 / 1